Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 9/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 9/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.43 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.43 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.43 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.43 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.43 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL308214 | 0.86 | KDM4E (0.47) | SMN1; SMN2HDAC1HDAC6HDAC3HDAC4 | |
| SCHEMBL308968 | 0.78 | HSP90AA1 (0.43) | LMNAHDAC1HDAC6HDAC3HDAC4 | |
| SCHEMBL29531976 | 0.78 | ALDH1A1 (0.49) | ALDH1A1SMN1; SMN2LTB4RKDM4EGAA | |
| SCHEMBL5856769 | 0.77 | ALDH1A1 (0.57) | ALDH1A1SMN1; SMN2LMNAHDAC1HDAC6 | |
| SCHEMBL1472555 | 0.76 | LMNA (0.66) | ALDH1A1SMN1; SMN2LMNAHDAC1HDAC6 | |
| Dipyridyl SCHEMBL25299271 | 0.73 | CCR1 (0.42) | SMN1; SMN2LMNAKDM4EGAAMAPT | |
| SCHEMBL11115889 | 0.73 | EPHX2 (0.54) | ALDH1A1LMNAKDM4EGAAMAPT | |
| SCHEMBL22350388 | 0.72 | LMNA (0.50) | ALDH1A1SMN1; SMN2LMNAHDAC1KDM4E | |
| Dipyridyl SCHEMBL5535016 | 0.72 | CCR1 (0.44) | — | |
| Dipyridyl SCHEMBL5312377 | 0.72 | CCR1 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160296147-A1 | Redox Polymers | THERASENSE, INC. | 2016-10-13 | — | — | US | disclosed |
| US-9320467-B2 | Redox polymers | ABBOTT DIABETES CARE INC. (US) | 2016-04-26 | — | — | US | disclosed |
| US-20140364710-A1 | Redox Polymers | THERASENSE, INC. | 2014-12-11 | — | — | US | disclosed |
| US-8828204-B2 | Redox polymers | ABBOTT DIABETES CARE INC. (US) | 2014-09-09 | — | — | US | disclosed |
| US-8795490-B2 | Redox polymers | ABBOTT DIABETES CARE INC. (US) | 2014-08-05 | — | — | US | disclosed |
| US-8512534-B2 | Redox polymers | ABBOTT DIABETES CARE INC. (US) | 2013-08-20 | — | — | US | disclosed |
| US-8444834-B2 | Redox polymers for use in analyte monitoring | ABBOTT DIABETES CARE INC. (US) | 2013-05-21 | — | — | US | disclosed |
| US-8268143-B2 | Oxygen-effect free analyte sensor | ABBOTT DIABETES CARE INC. (US) | 2012-09-18 | — | — | US | disclosed |
| US-8268143-B2 | Oxygen-effect free analyte sensor | ABBOTT DIABETES CARE INC. (US) | 2012-09-18 | — | — | US | disclosed |
| US-20120132525-A1 | REDOX POLYMERS FOR USE IN ANALYTE MONITORING | ABBOTT DIABETES CARE INC. | 2012-05-31 | — | — | US | disclosed |
| US-20110306111-A1 | Redox Polymers | ABBOTT DIABETES CARE INC. | 2011-12-15 | — | — | US | disclosed |
| US-20110303537-A1 | Redox Polymers | ABBOTT DIABETES CARE INC. | 2011-12-15 | — | — | US | disclosed |
| US-20110303538-A1 | Redox Polymers | ABBOTT DIABETES CARE INC. | 2011-12-15 | — | — | US | disclosed |
| US-7918976-B2 | Transition metal complexes with bidentate ligand having an imidazole ring | ABBOTT DIABETES CARE INC. (US) | 2011-04-05 | — | — | US | disclosed |
| US-20100288634-A1 | Transition Metal Complexes with Bidentate Ligand Having an Imidazole Ring | ABBOTT DIABETES CARE INC. | 2010-11-18 | — | — | US | disclosed |
| US-20090145757-A1 | Redox Polymers | ABBOTT DIABETES CARE INC. | 2009-06-11 | — | — | US | disclosed |
| US-20090145757-A1 | Redox Polymers | ABBOTT DIABETES CARE INC. | 2009-06-11 | — | — | US | disclosed |
| US-20090099434-A1 | OXYGEN-EFFECT FREE ANALYTE SENSOR | ABBOTT DIABETES CARE INC. | 2009-04-16 | — | — | US | disclosed |
| US-20090099434-A1 | OXYGEN-EFFECT FREE ANALYTE SENSOR | ABBOTT DIABETES CARE INC. | 2009-04-16 | — | — | US | disclosed |
| US-20070007132-A1 | Transition metal complexes with bidentate ligand having an imidazole ring | ABBOTT DIABETES CARE INC. | 2007-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090099434-A1 | OXYGEN-EFFECT FREE ANALYTE SENSOR | LPO, TXN2, PRDX5 | ALDH1A1 724/4885SMN1; SMN2 2487/4885LMNA 3343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.